EAST RUTHERFORD, N.J., Feb. 6, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Greg Sargen, Executive Vice President and Chief Financial Officer, will make a presentation on the Company at the UBS 22nd Annual Global Healthcare Services Conference on February 8, 2012 at 10:00 AM EST at the Grand Hyatt New York, New York City.
The slide presentation can be accessed from the Cambrex website http://www.cambrex.com in the Investors section of the website under Webcasts & Presentations.
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.
SOURCE Cambrex Corporation